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esistant S.aureus is one of the most important nosocomial
athogens with increasing global prevalence in recent 3 decades.
egarding to being carrier, medical students can be considered as
ne of the infection sources. The aim of this study was to assess the
revalence of nasal carriage of this organismin medical students.
Methods: In a cross-sectional study nasal swabs were collected
rom 466 medical students including 216 preclinical, 179 clinical
tudents and 71 residents. Samples were cultured on blood agar.
. aureus isolates were further analyzed for antibiotic resistance.
ach person was questioned for sex, grade, recent disease and drug
istory and family members’ employment in hospital.
Results: Of 466 students, 109 (23.4%) were nasal car-
ier of S. aureus. According to the educational categories, 52
94.1%) pre-clinical students, 39 (21.7%) clinical students, and
8 (25.3%) residents were carrier. No signiﬁcant association
as observed between nasal carrier rates and educational cat-
gories. Most isolates were resistant to penicillin (97.2%), and
3.2%weremethicillin-resistant.Mostmethicillin-resistant strains
ere isolated from clinical students (76.3%, p<0/001), and most
ancomycin-resistant isolates were found in residents (41.2%,
<0/001).
Conclusion: The rate of nasal carriage of S.aureus in medical
tudents was similar to general population and hospital personnel,
ut the rates of MRSA and vancomycin-resistant S. aureus carriers
re higher in medical students.
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rend of penicillin-resistant Streptococcus pneumoniae in a ter-
iary teaching hospital in Malaysia
.A. Hassan ∗, I. Nabilah, M. Zeehaida, H. Habsah
Universiti Sains Malaysia, Kota Bharu, Malaysia
Background: Antimicrobial resistance is a worldwide health-
are problem. Geographic variations in the resistance of various
acterial pathogens are notable in Asia. Regarding Streptococ-
us pneumonia, the Asian Network for Surveillance of Resistant
athogens (ANSORP) study demonstrated that Asians had the
orld’s highest level of antimicrobial resistance. Increasing preva-
ence rates of -lactam- and macrolide-resistant S. pneumoniae
trainshavebeenobserved inmanycountries. Theaimof the survey
as to determine the prevalence of Penicillin-resistant Streptococ-
us pneumoniae (PRSP) in our hospital
Methods: Retrospective laboratory based analysis of bacte-
ial isolates from clinical specimens in Hospital Universiti Sains
alaysia (HUSM) from January 2001 to December 2011 was done.
ntimicrobial susceptibility was determined using disc diffusion
ethod and the minimum inhibitory concentration against peni-
illin was determined by Etest. The susceptibility was interpreted
ccording to the Clinical and Laboratory Standards Institute (CLSI).
ata were analyzed and presented as descriptive statistic.
Results: A total of 686 Streptococcus pneumoniae were isolated.wenty isolates (2.9%) were PRSP. Majority of PRSP were iso-
ated from sputum (n=9) followed by tracheal aspirates (n =6),
wab (n=3), and eye (n=1). There was only one case of inva-
ive PRSP. There were 16 isolates of Streptococcus pneumoniaefectious Diseases 16S (2012) e317–e473
from cerebrospinal ﬂuid however none of them were resistant to
penicillin. Yearly analysis revealed that the highest PRSP isolation
was in 2009 (n=7). The resistant rate of PRSP to trimethoprim-
sulfamethoxazolewas 63.2%, erythromycin 65.0%, cefotaxime 8.3%,
and chloramphenicol 25%. However, 100% sensitivitywas observed
in ceftriaxone, ceftazidime, cefuroxime, amoxicillin-clavulanic acid
and vancomycin.
Conclusion: Cases of PRSP were low in our hospital as com-
pared to other Asian country. Periodic surveillance of resistance
patterns is crucial to control cases of PRSN and establish guidelines
for the administration of appropriate antimicrobial agents against
this pathogen. Implementation and adherence to infection control
measures by every health care provider is crucial to control the
transmission of this pathogen.
http://dx.doi.org/10.1016/j.ijid.2012.05.572
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Multilocus sequence typing of clinical ESBL- producing E. coli
strains
W.S. Ho1,∗, K.-L. Thong2, C.C. Yeo3
1 University of Malaya, Kuala Lumpur, Malaysia
2 Institute of Biological Sciences, Laboratory of Biomedical Science
and Molecular Microbiology, University of Malaya, Kuala Lumpur,
Malaysia
3 Universiti Sultan Zainal Abidin, Kuala Terengganu, Malaysia
Background: Extended-spectrum beta-lactamase (ESBL) pro-
ducing Enterobacteriaceae is now a major problem in many
hospitals in Malaysia especially in the critical care settings and E.
coli is one of the most common organisms associated with ESBL
production. Currently, CTX-M is the most common type of ESBLs
with CTX-M-15 being the most prevalent genotype found in many
parts of the world except for Asia. The wide distribution of CTX-M-
15-producing E. coli strains globally has been partially contributed
by the dissemination of the E. coli O25-ST131 clone. Therefore,
the objective of this study was to detect the presence and preva-
lence of the E. coli O25-ST131 clone in our Malaysian strains and to
determine the sequence types of CTX-M positive strains via MLST
analysis.
Methods: PCR was used to detect and further subgroup the
CTX-M genes of 20 ESBL-producing E. coli clinical isolates using
established published primers. Speciﬁc detection of E. coli O25-
ST131 clone targeting the speciﬁc pabB gene was carried out. For
CTX-M producing-isolates that did not yield positive ampliﬁcation
for pabB gene, MLST was carried out using 7 housekeeping genes
to determine their sequence types.
Results: Among the 20 ESBL-producing E. coli isolates, 17 har-
bored CTX-M-15 genes and 2 harboured CTX-M-14. Four ESBL-
producing E .coli were positive for pabB gene indicating the pres-
ence of E. coli O25-ST131 clone. Using MLST, another common
sequence type was observed for the ESBL-producing E. coli: ST354
(n=3). Three O25-ST131 clones were CTX-M-15 positive while
another ST131 clone carried CTX-M-14. All three ST354 were CTX-
M-15 positive. Other sequence types such as ST10, ST46, ST57,
ST117, ST224, ST349, ST405, ST533, ST602 and ST617 (n=1) were
also identiﬁed.
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continued during the 2011-2012 inﬂuenza season, and the pending
results will be reported in our presentation.
http://dx.doi.org/10.1016/j.ijid.2012.05.57515th ICID Abstracts / International Journa
Conclusion: CTX-M-15 is the most common CTX-M genotype
ound in this study and this is the ﬁrst report on the emergence
f O25-ST131 clones in Malaysian E.coli isolates. Another common
equence type (ST354) for ESBL-producing E. coli was observed
hich has been reported. Other ESBL-producing E.coli isolateswere
enetically diverse as they shared different sequence types.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.573
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ynergistic effects of sodium chenodeoxycholic acid on antimi-
robial activities of -lactam antibiotics against -lactamase-
roducing Staphylococcus aureus
. Horie1,∗, A. Yamada2
Ohu University, Fukushima, Japan
The University of Shiga Prefecture, Shiga, Japan
Background: -lactamase-producing Staphylococcus aureus
ynthesizes a -lactamase which decomposes the -lactam ring,
nd consequently almost all -lactam antibiotics are inactivated
y the enzyme. The appearance of -lactamase-producing bacte-
ial strains has diminished the usefulness of -lactam antibiotics.
ew therapeutic agents or newapproaches are urgently needed for
rug-resistant bacteria. We investigated the antimicrobial activity
f sodium chenodeoxycholic acid against -lactamase-producing
. aureus strains, and the synergistic effects of sodium chenodeoxy-
holic acid on the antimicrobial activity of -lactam antibiotics
gainst those strains. The possibility of this combination as a
ew therapeutic method against infectious diseases caused by -
actamase-producing bacteria was examined.
Methods: The synergistic effects of the combined use of sodium
henodeoxycholic acid on the antimicrobial activities of -lactam
ntibiotics, including benzylpenicillin, ampicillin, amoxicillin and
iperacillin, against ﬁve isolates of penicillinase-producing S.
ureus were tested by using an MIC (minimum inhibitory concen-
ration) assay. The inhibitory effects on the penicillinase activity
nd on the synthesis of the penicillinase in penicillinase-producing
. aureus by sodium chenodeoxycholic acid were examined by
itroceﬁn assay.
Results: The MIC range of the four -lactams against
enicillinase-producing S. aureus strains was 32 to 128 g/mL. On
he other hand, the range of the combined use of sodium chen-
deoxycholic acid was 0.5 to 4 g/mL. The antimicrobial activities
f -lactam antibiotics to the strains were obviously enhanced by
he combination with sodium chenodeoxycholic acid. In addition,
t was demonstrated that the sodium chenodeoxycholic acid sig-
iﬁcantly reduced (p<0.01) the synthesis of the penicillinase in
enicillinase-producing S. aureus, but did not suppress the peni-
illinase activity.
Conclusion: Chenodeoxycholic acid have already been used
egularly as cholagogue, a choleretic laxative, and to prevent or dis-
olve gallstones in the medical practice. Therefore, there is hardly
ny problem in safety for the human body. Although further anal-
sis is necessary, investigation of the synergistic effects of sodium
henodeoxycholic acid on the antimicrobial activity is expected to
eanewtherapeuticmethodandmaycontribute toaneffectiveuti-fectious Diseases 16S (2012) e317–e473 e417
lization of -lactam antibiotics against infectious diseases caused
by -lactamase-producing bacteria.
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In vitro neuraminidase inhibitory activities of four neu-
raminidase inhibitors against inﬂuenza viruses isolated in the
2010-2011 and 2011-2012 inﬂuenza seasons in Japan
H. Ikematsu1,∗, N. Kawai2, N. Iwaki3, S. Kashiwagi4
1 Kyushu University, Fukulka, Japan
2 Japan Physicians Association, Tokyo, Japan, Gifu, Japan
3 Japan Physicians Association, Tokyo, Japan, Ishikawa, Japan
4 Japan Physicians Association, Tokyo, Japan, Fukuoka, Japan
Background: In the 2010-2011 inﬂuenza season, four neu-
raminidase inhibitors (NAIs), oseltamivir phosphate (Tamiﬂu®),
zanamivir (Relenza®), laminamivir octanoate (Inavir®), and
peramivir (Rapiacta®), were available for the treatment of
inﬂuenza in Japan. To study the extent of drug resistance to each
NAI, wemeasure the halfmaximal inhibitory concentrations (IC50)
of the four NAIs with inﬂuenza viruses isolated in the 2010-2011
and 2011-2012 inﬂuenza seasons.
Methods: Inﬂuenza viruses were isolated from nasal aspiration,
nasopharyngeal swab, or self-blown nasal discharge obtained from
patients before treatment. Madine-Darby canine kidney cells were
used for viral isolation. The type and subtypes of A(H1N1)pdm09,
H3N2 or B were determined by RT-PCR using type and subtype
speciﬁc primers. The IC50 was determined by a ﬂuorescence-based
neuraminidase inhibition assay. NA sequences were directly deter-
mined from clinical samples.
Results: A(H1N1)pdm09, H3N2, and B viruses were isolated
in the 2010-2011 season from 185, 54, and 30 patients, respec-
tively. The geometric means of IC50 for oseltamivir carboxylate
were 0.86 nM, 0.73 nM, and 33.12 nM for A(H1N1)pdm09, H3N2,
and B, respectively. Similarly, the geometric means of IC50 for the
other three NAIs were lowest for A(H1N1)pdm09 and highest for B
viruses. TwooutlierA(H1N1)pdm09 isolates showedveryhigh IC50
values for oseltamivir (840 nM and 600 nM) and peramivir (19 nM
and 24 nM). H275Y mutation was found in both of these isolates.
No isolates showed signiﬁcantly high IC50 values for zanamivir or
laninamivir.
Conclusion:A(H1N1)pdm09 isolates obtained in the2010-2011
season from2of 269 patients showed signiﬁcantly high IC50 values
for oseltamivir carboxylate and peramivir. In contrast, all isolates
were sensitive to zanamivir and laninamivir. The study is being
